Who
Brian P. McKeon
Director
Company insider
Files Form 4 as: Director, Dentsply Sirona; Director, Alkermes; EVP, CFO and Treasurer, IDEXX Laboratories; Director, Athenahealth; Chief Financial Officer, Iron Mountain Incorporated (Delaware); EVP - F & A; CFO, Timberland Co.
In numbers
- Trades disclosed
- 631
- Buys
- 4
- Sells
- 29
- Bought
- $787K
- Sold
- $117.0M
- Companies
- 6
- Companies where not an officer
- 3
- First trade
- 30 Dec 2005
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Bought | $101K10,000 at $10.12 | filing |
| 12 Jun 2026filed 15 Jun 2026 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Bought | $101K10,000 at $10.12 | filing |
| 3 Jun 2026filed 5 Jun 2026 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Code A | —28,887 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Code A | —28,887 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code M | —6,142 | filing |
| 21 May 2026filed 22 May 2026 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code F | $55K1,475 at $36.95 | filing |
| 21 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,142 | filing |
| 21 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,142 | filing |
| 21 May 2026filed 22 May 2026 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code M | —6,142 | filing |
| 21 May 2026filed 22 May 2026 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code F | $55K1,475 at $36.95 | filing |
| 20 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —11,538 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —11,538 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,409 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,409 at $0.00 | filing |
| 31 May 2025filed 2 Jun 2025 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,013 | filing |
| 31 May 2025filed 2 Jun 2025 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code M | —8,013 | filing |
| 31 May 2025filed 2 Jun 2025 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code F | $59K1,924 at $30.61 | filing |
| 21 May 2025filed 23 May 2025 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —13,474 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,142 at $0.00 | filing |
| 14 Feb 2025filed 18 Feb 2025 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —252 at $0.00 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5XRAY · manilatimes.net · 20 Oct 2026DENTSPLY SIRONA (NASDAQ:XRAY) & Envoy Medical (NASDAQ:COCH) Financial AnalysisXRAY · tickerreport.com · 19 Oct 2026IceCure Medical (NASDAQ:ICCM) and DENTSPLY SIRONA (NASDAQ:XRAY) Head-To-Head ReviewXRAY · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name Brian P. McKeon; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.